Treatment with Saccharomyces boulardii and Escherichia coli Nissle is safe and associated with reduced nosocomial transmission of vanB vancomycin-resistant Enterococcus faecium on an early rehabilitation ward in Germany: a retrospective analysis

References

• JohnGWangLNanavatiJTwoseCSinghRMullinGDietary alteration of the gut microbiome and its impact on weight and fat mass: a systematic review and meta-analysisGenes201893167
   PubMed Web of Science ®Google Scholar
• SivananthanKPetersenAMReview of Saccharomyces boulardii as a treatment option in IBDImmunopharmacol Immunotoxicol201811111
   Google Scholar
• MieleEShamirRAloiMNutrition in pediatric inflammatory bowel diseaseJ Pediatr Gastroenterol Nutr201866468770829570147
   PubMed Web of Science ®Google Scholar
• HedgeDDStrainJDFarverDRNew advances in the treatment of Clostridium difficile infection (CDI)TCRM200845949964
   Google Scholar
• HendausMJomhaFEhlayelMAllergic diseases among children: nutritional prevention and interventionTCRM201612361
   Web of Science ®Google Scholar
• MarkowiakPŚliżewskaKEffects of probiotics, prebiotics, and synbiotics on human healthNutrients2017991021
   PubMed Web of Science ®Google Scholar
• VitettaLVitettaGHallSImmunological tolerance and function: associations between intestinal bacteria, probiotics, prebiotics, and phagesFront Immunol20189224030356736
   PubMed Web of Science ®Google Scholar
• KandasamySVlasovaANFischerDDUnraveling the differences between gram-positive and gram-negative probiotics in modulating protective immunity to enteric infectionsFront Immunol201789126229051764
   PubMed Web of Science ®Google Scholar
• SonnenbornURobertsonLEscherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic propertiesFEMS Microbiol Lett201636319fnw21227619890
   PubMed Web of Science ®Google Scholar
• StierHBischoffSCSaccharomyces boulardii CNCM I-745 on the gut-associated immune system20169269279
   Google Scholar
• McFarlandLVMeta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile diseaseAm J Gastroenterol2006101481282216635227
   PubMed Web of Science ®Google Scholar
• TacconelliECarraraESavoldiADiscovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisLancet Infect Dis201818331832729276051
   PubMed Web of Science ®Google Scholar
• O’DriscollTCrankCWVancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal managementInfect Drug Resist2015821723026244026
   PubMed Web of Science ®Google Scholar
• UlrichNVonbergR-PGastmeierPOutbreaks caused by vancomycin-resistant Enterococcus faecium in hematology and oncology departments: A systematic reviewHeliyon2017312e0047329322099
   PubMed Web of Science ®Google Scholar
• BorgmannSNiklasDMKlareITwo episodes of vancomycin-resistant Enterococcus faecium outbreaks caused by two genetically different clones in a newborn intensive care unitInt J Hyg Environ Health2004207438638915471103
   PubMed Web of Science ®Google Scholar
• RemschmidtCBehnkeMKolaAThe effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic studyAntimicrob Resist Infect Control2017619528924472
   PubMed Web of Science ®Google Scholar
• ScheichSLindnerSKoenigRClinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemiaCancer2018124228629628960264
   PubMed Web of Science ®Google Scholar
• PuchterLChabernyIFSchwabFVonbergRPBangeFCEbadiEEconomic burden of nosocomial infections caused by vancomycin-resistant enterococciAntimicrob Resist Infect Control201871129312658
   PubMed Web of Science ®Google Scholar
• TopJSinnigeJCMajoorEABontenMJWillemsRJvan SchaikWThe recombinase IntA is required for excision of esp-containing ICEEfm1 in Enterococcus faeciumJ Bacteriol201119341003100621148730
   PubMed Web of Science ®Google Scholar
• Laverde GomezJAvan SchaikWFreitasARA multiresistance megaplasmid pLG1 bearing a hylEfm genomic island in hospital Enterococcus faecium isolatesInt J Med Microbiol2011301216517520951641
   PubMed Web of Science ®Google Scholar
• BorgmannSPfeiferYBeckerLRießBSiegmundRSagelUFindings from an outbreak of carbapenem-resistant Klebsiella pneumoniae emphasize the role of antibiotic treatment for cross transmissionInfection201846110311229177610
   PubMed Web of Science ®Google Scholar
• BorgmannSRießBvon Wernitz-KeibelTMatthias BuehlerMStrommengerBLayerFRecovery of a 10-year-old girl from methicillin-resistant Staphylococcus aureus sepsis in response to low-dose ceftaroline treatmentTCRM201612749753
   Web of Science ®Google Scholar
• StegerSDemetzFSchmidtCBorgmannSLow percentage of asylum seekers colonized with Multi-Resistant bacteria treated at a German hospitalJacobs J Epidemiol Prev Med20162121
   Google Scholar
• RyanLO’MahonyEWrennCEpidemiology and molecular typing of VRE bloodstream isolates in an Irish tertiary care hospitalJ Antimicrob Chemother201570102718272426142479
   PubMed Web of Science ®Google Scholar
• D’AgataEMGautamSGreenWKTangYWTangYHigh rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococciClin Infect Dis200234216717211740703
   PubMed Web of Science ®Google Scholar
• BrasgIElligsenMMacFaddenDDanemanNPredictive utility of swab screening for vancomycin-resistant enterococcus in selection of empiric antibiotics for Enterococcus sterile-site infections: a retrospective cohort studyCMAJ Open201753E632E637
   PubMedGoogle Scholar
• RemschmidtCSchröderCBehnkeMGastmeierPGeffersCKramerTSContinuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany − 10 years of surveillanceAntimicrob Resist Infect Control201871217
   Web of Science ®Google Scholar
• van LoonKVoor In ‘t HoltAFVosMCA systematic review and meta-analyses of the clinical epidemiology of carbapenem-resistant EnterobacteriaceaeAntimicrob Agents Chemother2018621e017301729038269
   PubMed Web of Science ®Google Scholar
• VidalMForestierCCharbonnelNHenardSRabaudCLesensOProbiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humansJ Clin Microbiol20104872595259820421444
   PubMed Web of Science ®Google Scholar
• CrouzetLRigottier-GoisLSerrorPPotential use of probiotic and commensal bacteria as non-antibiotic strategies against vancomycin-resistant enterococciFEMS Microbiol Lett20153628fnv01225667231
   PubMed Web of Science ®Google Scholar
• UbedaCBucciVCaballeroSIntestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonizationInfect Immun201381396597323319552
   PubMed Web of Science ®Google Scholar
• StiefelUNerandzicMMPultzMJDonskeyCJGastrointestinal colonization with a cephalosporinase-producing bacteroides species preserves colonization resistance against vancomycin-resistant enterococcus and Clostridium difficile in cephalosporin-treated miceAntimicrob Agents Chemother20145884535454224867962
   PubMed Web of Science ®Google Scholar
• CrouzetLDerrienMCherbuyCLactobacillus paracasei CNCM I-3689 reduces vancomycin-resistant Enterococcus persistence and promotes Bacteroidetes resilience in the gut following antibiotic challengeSci Rep201881509829572473
   PubMed Web of Science ®Google Scholar
• TytgatHLDouillardFPReunanenJLactobacillus rhamnosus GG Outcompetes Enterococcus faecium via Mucus-Binding Pili: Evidence for a Novel and Heterospecific Probiotic MechanismAppl Environ Microbiol201682195756576227422834
   PubMed Web of Science ®Google Scholar
• LiMLeeKHsuMNauGMylonakisERamratnamBLactobacillus-derived extracellular vesicles enhance host immune responses against vancomycin-resistant enterococciBMC Microbiol20171716628288575
   PubMed Web of Science ®Google Scholar
• TopcuogluSGursoyTOvalıFSerceOKaratekinGA new risk factor for neonatal vancomycin-resistant Enterococcus colonisation: bacterial probioticsJ Matern Fetal Neonatal Med201528121491149425163639
   PubMed Web of Science ®Google Scholar
• Drug Commission of the German Medical AssociationNeue Kontraindikation von Saccharomyces boulardii (Saccharomyces cerevisiae HANSEN CBS 5926) bei schwerkranken oder immunsupprimierten Patienten [German]. Available from: https://www.akdae.de/Arzneimit-telsicherheit/RHB/Archiv/2018/20180122.pdfAccessed July 11, 2018
   Google Scholar